*Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; †Division of Gastroenterology and Nutrition, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts; ‡Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts; §Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and ‖Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Inflamm Bowel Dis. 2017 Nov;23(11):1898-1904. doi: 10.1097/MIB.0000000000001236.
High intake of dietary n-3 polyunsaturated fatty acids (PUFA) is associated with a decreased risk of ulcerative colitis (UC) and Crohn's disease (CD). However, results have been heterogeneous suggesting that genetic variations in PUFA metabolism may modify this risk.
We conducted a case-control study nested within 2 prospective cohorts, the Nurses' Health Study (NHS) and NHS II. Among women providing blood (n = 62,437) or buccal cells (n = 59,543) for genotyping, we confirmed new diagnoses of CD or UC. Dietary intake was assessed 4 years before diagnosis. Confirmed cases were matched 1:2 to controls. Subjects were genotyped for single nucleotide polymorphisms at CYP4F3, FADS1, and FADS2 loci. Conditional logistic regression models examined the interaction between genotype, n3:n6 PUFA intake and risk of CD and UC.
Our study included 101 CD and 139 UC patients matched to 495 controls. On multivariable analysis, high intake of n3:n6 PUFA (above median) demonstrated a trend toward reduced risk of UC (Odds ratio [OR] 0.71, 95% confidence interval [CI], 0.47-1.09, P = 0.11). High n3:n6 PUFA intake was associated with a reduced risk of UC in individuals with the GG/AG genotype at a single nucleotide polymorphism in CYP4F3 (OR 0.57, 95% CI, 0.32-0.99) but not those with the AA genotype (OR 0.95, 95% CI, 0.47-1.93) (P-interaction = 0.049). No gene-diet interactions were noted for CD.
The association between dietary n3:n6 PUFA intake and risk of UC may be modified variants at CYP4F3. Further gene-environment studies of the association between diet and IBD risk are warranted.
大量摄入膳食 n-3 多不饱和脂肪酸(PUFA)与溃疡性结肠炎(UC)和克罗恩病(CD)的风险降低有关。然而,结果存在异质性,提示 PUFA 代谢的遗传变异可能会改变这种风险。
我们进行了一项病例对照研究,嵌套在两个前瞻性队列中,即护士健康研究(NHS)和 NHS II。在为基因分型提供血液(n=62437)或颊细胞(n=59543)的女性中,我们确认了 CD 或 UC 的新诊断。在诊断前 4 年评估饮食摄入情况。将确诊病例与对照按 1:2 配对。对 CYP4F3、FADS1 和 FADS2 基因座的单核苷酸多态性进行基因分型。条件逻辑回归模型检查了基因型、n3:n6 PUFA 摄入与 CD 和 UC 风险之间的相互作用。
我们的研究包括 101 例 CD 和 139 例 UC 患者,与 495 例对照相匹配。多变量分析显示,n3:n6 PUFA 摄入较高(中位数以上)与 UC 风险降低呈趋势相关(比值比[OR]0.71,95%置信区间[CI]0.47-1.09,P=0.11)。在 CYP4F3 单一核苷酸多态性的 GG/AG 基因型个体中,高 n3:n6 PUFA 摄入与 UC 风险降低相关(OR0.57,95%CI0.32-0.99),但在 AA 基因型个体中则不然(OR0.95,95%CI0.47-1.93)(P 交互=0.049)。未发现 CD 基因-饮食相互作用。
膳食 n3:n6 PUFA 摄入与 UC 风险之间的关联可能与 CYP4F3 中的变异有关。进一步研究饮食与 IBD 风险之间的关联的基因-环境研究是必要的。